XML 41 R25.htm IDEA: XBRL DOCUMENT
v3.20.4

Variable Interest Entities (VIEs) | 12 Months Ended
--- | ---
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Variable Interest Entities (VIEs) | Variable Interest Entities (VIEs) A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE. The Company follows guidance on the consolidation of VIEs that requires companies to utilize a qualitative approach to determine whether it is the primary beneficiary of a VIE. See Note 2 to the accompanying consolidated financial statements for information on how the Company determines VIEs and its treatment. The following table includes assets that can only be used to settle the liabilities of APC and the creditors of APC have no recourse to the Company. These assets and liabilities, with the exception of the investment in a privately held entity and amounts due to affiliate, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands).
|  | December 31,
|  | 2020 |  | 2019
Assets |  |  |  |
Current assets |  |  |  |
Cash and cash equivalents |  | $ | 126,158 |  |  | $ | 87,110 |
Restricted cash – short-term |  | — |  |  | 75 |
Investment in marketable securities |  | 67,637 |  |  | 123,948 |
Receivables, net |  | 5,155 |  |  | 9,300 |
Receivables, net – related party |  | 46,718 |  |  | 42,976 |
Other receivables |  | 1,084 |  |  | 744 |
Prepaid expenses and other current assets |  | 14,813 |  |  | 7,403 |
Loans receivable |  | 50 |  |  | 6,425 |
Loans receivable - related parties |  | — |  |  | 16,500 |
Total current assets |  | 261,615 |  |  | 294,481 |
Noncurrent assets |  |  |  |
Land, property and equipment, net |  | 27,599 |  |  | 9,547 |
Intangible assets, net |  | 69,250 |  |  | 81,439 |
Goodwill |  | 109,460 |  |  | 108,913 |
Loans receivable – related parties |  | 4,145 |  |  | — |
Investment in affiliates* |  | 225,144 |  |  | 318,315 |
Investments in other entities – equity method |  | 43,516 |  |  | 28,427 |
Investment in privately held entities |  | 36,584 |  |  | 1,615 |
Restricted cash – long-term |  | 500 |  |  | 746 |
Operating lease right-of-use assets |  | 6,298 |  |  | 4,751 |
Other assets |  | 17,177 |  |  | 1,057 |
Total noncurrent assets |  | 539,673 |  |  | 554,810 |
Total assets |  | $ | 801,288 |  |  | $ | 849,291 |
Current liabilities |  |  |  |
Accounts payable and accrued expenses |  | $ | 12,963 |  |  | $ | 11,187 |
Fiduciary accounts payable |  | 9,642 |  |  | 2,027 |
Medical liabilities |  | 37,684 |  |  | 49,019 |
Income taxes payable |  | 4,225 |  |  | 4,530 |
Dividend payable |  | 485 |  |  | 271 |
Amount due to affiliate |  | 22,698 |  |  | 28,058 |
Current portion of long-term debt |  | 201 |  |  | — |
Finance lease liabilities |  | 102 |  |  | 102 |
Operating lease liabilities |  | 1,242 |  |  | 1,088 |
Total current liabilities |  | 89,242 |  |  | 96,282 |
Noncurrent liabilities |  |  |  |
Long-term debt, net of current portion |  | 7,379 |  |  | — |
Deferred tax liability |  | 9,144 |  |  | 14,059 |
Liability for unissued equity shares |  | — |  |  | — |
Finance lease liabilities, net of current portion |  | 311 |  |  | 416 |
Operating lease liabilities, net of current portion |  | 5,242 |  |  | 3,742 |
Total noncurrent liabilities |  | 22,076 |  |  | 18,217 |
Total liabilities |  | $ | 111,318 |  |  | $ | 114,499 |
*Investment in affiliates include APC’s investment in ApolloMed which is reflected as treasury shares and eliminated upon consolidation. As a result this balance is not reflected on ApolloMed’s consolidated balance sheets as of December 31, 2020 and 2019.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -URI http://asc.fasb.org/topic&trid=2197479 + Details
Name: | us-gaap_VariableInterestEntityDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration